Daily stock price indexes of selected pharmaceuticals firms 2020-2024

Published by Statista Research Department, Sep 3, 2024

This statistic shows the stock price development of selected companies in the pharmaceuticals industry from January 6, 2020 to April 15, 2024. After developing and distributing effective vaccines against COVID-19, the stock values of BioNTech and Moderna increased substantially during this period. Moderna's stock value increased by close to 1,700 percent between January 2020 and October 2021. Similarly, BioNTech saw its highest valuation in August 2021. In comparison, the stock prices of Pfizer and Roche remained rather stable throughout the period considered.

Daily stock price indexes of selected pharmaceuticals companies from January 6, 2020 to April 15, 2024

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

April 2024

Region

Worldwide

Survey time period

January 6, 2020 to April 15, 2024

Supplementary notes

Index base: 100 = January 6, 2020

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " BioNTech "

The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you BioNTech

Overview

5

Key figures

5

Competitors

6

COVID-19 vaccine

5

Further Content: You might find this interesting as well

Topics

BioNTechBiotech drugsmRNA technologyCoronavirus disease (COVID-19) pandemicCoronavirus (COVID-19) in the U.S.
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.